| ALI | Acute lung injury |
| SIRS | Systemic inflammatory response syndrome |
| Sepsis-3 | The publication of the third international consensus definition of sepsis and septic shock |
| qSOFA | Quick SOFA |
| ARDS | Acute respiratory distress syndrome |
| TNF-α | Tumor necrosis factor-α |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| NF-κB | Nuclear factor-κB |
| PI3K | Phosphatidylinositol-3 kinase |
| AKT | Protein kinase B |
| MNK | Mitogen-activated protein kinase interacting kinases |
| ErK | Extracellular signal-regulated kinase |
| LPS | Lipopolysaccharide |
| PI3Kδ/γ | Phosphoinositide 3-kinase delta/gamma pathway |
| ROCK | Rho-associated protein kinase |
| Tie2 | Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2 |
| MD2 | Myeloid differentiation factor 2 |
| TLR4 | Toll-like receptor 4 |
| TLRs | Toll-like receptors |
| TNF | Tumor necrosis factor |
| ILs | Interleukins |
| ROS | Reactive oxygen species |
| PAMPs | Pathogen-associated molecular patterns |
| DAMPs | Damage-associated molecular patterns |
| CLP | Cecal ligation and puncture |
| WT | Wild-type |
| MyD88 | Myeloid differentiation primary response 88 |
| IL-1R | Interleukin-1 receptor |
| IRAK | IL-1R-associated kinase |
| NOX | NADPH oxidase |
| O2− | Superoxide anion |
| AMPK | Adenosine monophosphate-activated protein kinase |
| ECM1 | Extracellular matrix protein 1 |
| STAT5 | Signal transducer and activator of transcription 5 |
| NLRP3 | Nucleotide-binding oligomerization domain-like receptor protein 3 |
| TAN | Tangeretin |
| PLK1 | Polo-like kinase 1 |
| DRP1 | Dynamin-related protein 1 |
| STAT3 | Signal transducer and activator of transcription 3 |
| GSDM | Gasdermin D |
| ERRα | Estrogen-related receptor alpha |
| Pla2g2a | Phospholipase A2 type IIA |
| EGFR | Epidermal growth factor receptor |
| MUC1 | Mucin 1 |
| miR-199a | microRNA 199a |
| DHM | Dihydromyricetin |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| HO-1 | Heme oxygen-ase-1 |
| ICAM | Intercellular adhesion molecule |
| iNOS | Inducible nitric oxide synthase |
| SOD | Superoxide dismutase |
| CAT | Catalase |
| NO | Nitric oxide |
| ISL | Isoliquiritigenin |
| MDA | Malondialdehyde |
| GSH | Glutathione |
| MIF | Macrophage inhibitory factor |
| JAK2 | Janus kinase 2 |
| GA | Glycyrrhizic acid |
| Rg1 | Ginsenoside Rg1 |
| AS-IV | Astragaloside IV |
| BA | Betulinic Acid |
| cAMP | Cyclic adenosine monophosphate |
| cGMP | Cyclic guanosine monophosphate |
| ER-β | Estrogen receptor-β |
| MAPKs | Mitogen-activated protein kinases |
| EPCR | Endothelial protein C receptor |
| MPO | Myeloperoxidase |
| JNK | c-JunN-terminalkinases |
| mTOR | Mammaliantarget of rapamycin |
| IKK | Inhibitor of kappa B kinase |
| VEGF | Vascular endothelial growth factor |
| AP-1 | Activator protein-1 |
| PGC-1α | Peroxisome proliferator-activated receptor-γ coactivator 1-α |
| CaMKII | Ca2+/calmodulin-dependent protein kinase II |
| MLCK | Myocin light chain kinase |
| HMGB1 | High mobility group protein 1 |
| MMP-9 | Matrix metalloproteinase 9 |
| MH-S | Mouse alveolar macrophages |
| COX-2 | Cyclooxygenase-2 |
| SMAD3 | Mothers against decapentaplegic homolog 3 |
| Bcl-2 | B-Cell CLL/Lymphoma 2 |
| Bax | BCL2-associated X protein |
| Caspase-1 | Cysteine-requiring aspartate protease-1 |